Favorites and recent references stay on this device. No patient data is stored.
Choose the species
One selection filters the source overview, clinical facts, reports and dose calculator. Literature references are not species-filtered.
Choose one species for its overview and dose calculator, or all species to browse the full evidence.
Source overview
Recorded excerpts for one species. Each dose remains a separate source entry; no regimen is selected.
No clinical assertions recorded for an overview.
View full clinical evidence and sources ↓Clinical evidence
Dose regimens0
No dose regimens recorded for this species selection.
Adverse effects117
These are counts of spontaneously reported events, not proven adverse effects, causal relationships, or incidence rates.
Bars compare report counts within each species; they do not show incidence.
More reportsFewer reportsDog
- Death by euthanasia2,371 reports
- Lethargy (see also Central nervous system depression in Neurological)2,229 reports
- Polydipsia1,620 reports
- Ataxia1,586 reports
- Vomiting1,533 reports
- Seizure NOS1,532 reports
- Polyuria1,517 reports
- Diarrhoea1,455 reports
- Urinary incontinence1,359 reports
- Death1,221 reports
- Lack of efficacy - NOS1,162 reports
- Limb weakness1,142 reports
Cat
- Prescribing error3 reports
- Accidental exposure2 reports
- Lethargy (see also Central nervous system depression in Neurological)2 reports
- Vomiting2 reports
- Abdominal discomfort1 reports
- Abnormal posture NOS1 reports
- Decreased appetite1 reports
- Diarrhoea1 reports
- Elevated alanine aminotransferase (ALT)1 reports
- General pain (see other SOCs for specific pain)1 reports
- Itching1 reports
- Limb weakness1 reports
Literature references15
References are linked to this drug. Species applicability is not recorded here, so the species filter does not narrow this list. Imported dates do not retain their original precision; confirm dates in the original citation.
- Bedinvetmab (Librela/Beransa) in dogs raises safety concerns, including rapidly progressive osteoarthritis, and warrants vigilant adverse event reporting.
Study summary not available in the imported record. Open the original citation to review the study.
- Efficacy of bedinvetmab on pain, activity, and body composition in obese dogs with osteoarthritis: A randomized double-blind placebo-controlled trial.
Study summary not available in the imported record. Open the original citation to review the study.
- A critical appraisal of the safety of bedinvetmab (Beransa), a canine antinerve growth factor monoclonal antibody.
Study summary not available in the imported record. Open the original citation to review the study.
- Bedinvetmab, alone or in combination with photobiomodulation and pulsed electromagnetic field therapy, on pain and quality of life in dogs with hip osteoarthritis.
Study summary not available in the imported record. Open the original citation to review the study.
- A noninferiority trial evaluating the efficacy of bedinvetmab compared to grapiprant for osteoarthritis-pain in dogs using force plate gait analysis.
Study summary not available in the imported record. Open the original citation to review the study.
Sources: PubMed, National Library of Medicine; openFDA, U.S. Food and Drug Administration.
Available products
Products listed in the Health Canada Drug Product Database for this active ingredient. A listing does not establish that a product is authorized for the clinical uses described on this page.